Amomed Pharma GmbH
Amomed Pharma GmbH
Contact:
Beatrix Mick Schrempf
Phone: +43 1 545 01 13-26
E-Mail: b.mick-schrempf@amomed.com
KEYWORDS:
  • medical drugs
  • health
  • medicine
Download Photos
Amomed Pharma GmbH (100 releases)

A new therapeutic option for septic shock has now been approved for and is available in 26 European countries. Sepsis affects 27-30 million people and leads to eight million deaths worldwide every year. Septic shock is caused by a generalized bacterial infection and is associated with higher morbidity and mortality as well as extended invalidity. Most importantly, sepsis has negative effects on the cardiovascular system. Blood pressure drops, consciousness is clouded, the heart rate and respiratory rate increase. Worsened macro and micro-circulation leads to impaired blood flow to organs and ultimately to organ damage. [more]

Neurological diseases on the rise: European collaboration in research essential
2017-06-24, ptp20170624004 Health/Medicine, Science/Technology
Cannabinoids suitable for migraine prevention
2017-06-24, ptp20170624002 Health/Medicine, Science/Technology
EFORT Congress focusses on sports and orthopaedics
2017-05-31, ptp20170531027 Health/Medicine, Sport/Events
EFORT Congress in Vienna
2017-05-31, ptp20170531026 Health/Medicine, Sport/Events
Media alert: News in orthopaedics and traumatology - 18th EFORT Congress
2017-05-19, ptp20170519043 Health/Medicine, Sport/Events
WFN Media Release October 2017 - "Stroke clearly is a brain disease"
2016-10-17, ptp20161017025 Health/Medicine, Science/Technology
The role of opioids and weight loss in joint pain
2016-09-24, ptp20160924004 Health/Medicine, Science/Technology
EFIC Symposium: New therapeutic strategies to combat joint pain
2016-09-23, ptp20160923008 Health/Medicine, Science/Technology

1 2 3 4 5 6 7 8 9 10 Next »